Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

AMLESSA TABLETS 8 mg/ 10 mg

Approval Number

SIN15726P

Drug Name

AMLESSA TABLETS 8 mg/ 10 mg

Product Name

AMLESSA TABLETS 8 mg/ 10 mg

Approval Date

June 27, 2019

Registrant

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Licence Holder

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

Registrant

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Licence Holder

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

C09BB04

ATC Item Name

perindopril and amlodipine

Manufacturer Information

Pharmaceutical Manufacturer

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Manufacturers

Krka, d.d., Novo mesto

Active Ingredients

Ingredient Name

Perindopril 6.68 mg eqv. to Perindopril tert-Butylamine

Strength

8.00 mg

Drug MonographPerindopril

Ingredient Name

Amlodipine besilate 13.870 mg eqv. to amlodipine

Strength

10.0mg

Drug MonographAmlodipine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

AMLESSA TABLETS 8 mg/ 10 mg - HSA Approval | MedPath